Perrigo Co. Plc (PRGO)
12.92
+0.08
(+0.62%)
USD |
NYSE |
Dec 16, 12:25
Perrigo Research and Development Expense (Annual): 112.20M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alkermes Plc | 239.63M |
| Amarin Corp. Plc | 17.86M |
| Jazz Pharmaceuticals Plc | 884.00M |
| Skye Bioscience, Inc. | 18.70M |
| Avadel Pharmaceuticals Plc | 15.20M |